Sleep Disorder; Breathing-Related
Conditions
Brief summary
Subjects who consent to participate in the research will undergo a simultaneous recording of inlab PSG and WatchPAT200 for comparing the WatchPAT data to PSG at an altitude of 8500'.
Detailed description
The efficacy of the WP200U will be evaluated by comparing it to the PSG manual scoring of sleep disordered breathing (SDB) parameter using the PSG manual scoring as a gold standard
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Male and females ≥ age 17yrs * Subject is able to read understand and sign the informed consent form. * Willing to sleep with the WP200U and PSG simultaneously in the sleep lab.
Exclusion criteria
* Use of one of the following medications: alpha blockers, short acting nitrates (less than 3 hours before the study). * Any condition that in the opinion of the investigator may adversely affect the safety of the patient or would limit the patient ability to complete the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of AHI and ODI as scored automatically by the WatchPAT compared to manual scoring of full night PSG. | 8 months. |
Countries
United States